Pomerantz LLP is investigating Sellas Life Sciences Group and some of its officers for possible securities fraud after the company delayed releasing results from a key phase 3 clinical trial for its drug Galinpepimut-S. The trial reached a critical event with the 80th patient death on August 28, 2026, which should have triggered result disclosure, but Sellas did not release the data as expected. Following this news, Sellas's stock price dropped 13.15% to $13.21. The investigation aims to determine if the company engaged in unlawful business practices, with potential class action participation available for investors.
The investigation into Sellas Life Sciences Group provides context for health sector activity on Pluang. Of 100 priced health-sector US stocks, 30 rose and 67 fell today. Notable movers include NUWE at USD 0.76 with a 5.53% gain, MCK at USD 897.98 up 5.17%, and CLPT at USD 11.64 down 4.67%, as of Oct 01, 2026 20:52 WIB.
S&P Global Ratings has upgraded EssilorLuxottica's long-term credit rating to A+ with a stable outlook, recognizing the company's strong organic growth, solid cash flow, and robust balance sheet. The rating agency highlighted EssilorLuxottica's strat...
Questrade now offers pre-market (7:30 am to 9:25 am ET) and post-market (4:00 pm to 4:15 pm ET) trading for equity options on 29 selected stocks and ETFs, including major names like AAPL and TSLA. This allows investors to respond to earnings reports ...
EssilorLuxottica announced that S&P Global Ratings has upgraded its long-term credit rating to A+ with a stable outlook. This upgrade recognizes the company's strong organic growth, consistent cash generation, and solid financial position. S&P also h...
EssilorLuxottica announced that S&P Global Ratings has upgraded its long-term credit rating to A+ with a stable outlook. This upgrade recognizes the company's strong organic growth, robust cash flow, and solid balance sheet. S&P also highlighted the ...
Man Group PLC has publicly disclosed an interest in 3.13% of RHI Magnesita N.V.'s ordinary shares, combining direct ownership and cash-settled derivatives as of October 22, 2026. Additionally, Man Group holds positions in Vesuvius plc, indicating str...
